APA (7th ed.) Citation

A, B., VV, R., V, J., M, A., M, H., HR, D., . . . LM, B. (2025). First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: A retrospective single-center analysis. Journal of cancer research and clinical oncology, 151(4), 150. https://doi.org/10.1007/s00432-025-06208-8

Chicago Style (17th ed.) Citation

A, Burkhard-Meier, et al. "First-line Pazopanib in Patients with Metastatic Epithelioid Hemangioendothelioma: A Retrospective Single-center Analysis." Journal of Cancer Research and Clinical Oncology 151, no. 4 (2025): 150. https://doi.org/10.1007/s00432-025-06208-8.

MLA (9th ed.) Citation

A, Burkhard-Meier, et al. "First-line Pazopanib in Patients with Metastatic Epithelioid Hemangioendothelioma: A Retrospective Single-center Analysis." Journal of Cancer Research and Clinical Oncology, vol. 151, no. 4, 2025, p. 150, https://doi.org/10.1007/s00432-025-06208-8.